Treatment of Chronic Obstructive Pulmonary Disease (COPD) by REGEND007 Cell Therapy

Clinical trial NCT07355868 · RECRUITING

Trial details

NCT number: NCT07355868
Sponsor: Regend Therapeutics
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease (COPD)

Start date: 2026-03-19
Primary completion: 2026-10-15
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.